CHAN, Ho Man,GU, Xiang-Ju Justin,HUANG, Ying,LI, Ling,MI, Yuan,QI, Wei,SENDZIK, Martin,SUN, Yongfeng,WANG, Long,YU, Zhengtian,ZHANG, Hailong,ZHANG, Ji Yue (jeff),ZHANG, Man,ZHANG, Qiong,ZHAO, Kehao
申请号:
TN2017000204
公开号:
TN2017000204A1
申请日:
2015.12.21
申请国别(地区):
TN
年份:
2018
代理人:
摘要:
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R<;sup>;1 <;/sup>;, R<;sup>;2 <;/sup>;, R<;sup>;3 <;/sup>;, R<;sup>;4 <;/sup>;, R<;sup>;5<;/sup>;, and n are as defined herein.<;br />;